Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2023
20/7 12:23
Company Announcement Net sales of DARZALEX ® in the second quarter of 202 3 totaled USD 2,431 million Genmab receives royalties on worldwide net sales from Janssen Biotech, Inc. (Janssen) COPENHAGEN, Denmark; July 20 , 2023 – Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales...